The ubiquitin-specific protease 18 (USP18) has two major functions: (a) it is a highly specific protease that cleaves the ubiquitin-like modifier ISG15 (interferon-stimulated gene 15) from proteins, and (b) independent from its enzymatic activity USP18 interacts with the type I interferon receptor and shuts off downstream signaling. The structures of USP18 and a USP18-ISG15 complex revealed the molecular basis of the unique specificity of the protease and might shed some light into its interaction with the interferon receptor.
Introduction
Ubiquitin-specific protease 18 (USP18) belongs to the family of deubiquitinating enzymes (DUBs) that regulate a plethora of cellular functions. These enzymes counteract covalent modification of proteins by ubiquitin and ubiquitin-like modifiers (Ubl) such as SUMO, ISG15, Nedd8, or FAT10. ISG15 (interferon-stimulated-gene 15) consists of two ubiquitin-like domains that are connected by a short linker region. Analogous to ubiquitination, ISG15 is conjugated to lysine residues of target proteins (ISGylation) via an isopeptide bond [1] . While ubiquitin is ubiquitously expressed in cells, expression and conjugation of ISG15 depend on stimulation predominantly by type I interferons (IFNs) [2] . Post-translational modification with ISG15 was shown to be involved in antiviral defense, genome stability, and tumorigenesis [3] [4] [5] [6] . ISGylation is a reversible process and several DUBs show reactivity toward ubiquitin and ISG15 in vitro [7] . It is currently unclear whether these DUBs also deconjugate both ubiquitin and ISG15 in vivo and whether this crossreactivity is physiologically relevant. USP18 is the only ISG15-specific protease identified so far and constitutes the major ISG15-deconjugating enzyme in vivo [8] [9] [10] . Like expression of ISG15, USP18 expression is strongly induced by type I IFNs. USP18 is a cysteine protease and belongs to the USP family of DUBs. The catalytic domains of USPs share a common three-dimensional architecture characterized by three domains which are referred to as finger, palm, and thumb domain [11] . Like other cysteine proteases, USPs harbor a catalytic triad composed of a cysteine, an aspartate, and a histidine residue that is located at the interface between Abbreviations IBB, ISG15-binding box; IFN, interferon; ISG15, interferon-stimulated gene 15 kDa; Ubl, ubiquitin-like; USP, ubiquitin-specific protease.
thumb and palm domain. In contrast to other USPs, USP18 does not contain characteristic protein interaction domains aside from the catalytic core. This is even more remarkable, as USP18 is a bifunctional protein that not only fulfills the aforementioned enzymatic functions but also negatively regulates type I IFN signaling irrespective of its catalytic activity [12, 13] . Mice and cells lacking USP18 exhibit an enhanced interferon response and USP18 knockout mice die upon injection with the IFN-inducing agent poly I:C [14] . It has been shown that this phenotype is rescued by an enzymatically inactive USP18 protein. The negative regulation of type I interferon signaling must therefore be entirely independent of the catalytic activity of USP18 [13] . Concordantly, IFN hypersensitivity and associated phenotypical alterations in USP18-deficient mice were not observed when only the catalytic activity of USP18 was inactivated [8, 12] . Recent work provided evidence that USP18 is recruited to the type I IFN receptor subunit IFNAR2 in a STAT2 (signal transducer and activator of transcription)-dependent manner where it interferes with IFN-mediated signaling [15] . The unique specificity for ISG15 and the nonenzymatic function in the absence of characteristic additional domains raises the question, which structural properties distinguish USP18 from other USPs that mainly target ubiquitin and are usually fused with additional characteristic protein interaction domains. We have recently determined the crystal structures of USP18 and of a USP18-ISG15 complex [16] . Analysis of structural characteristics complemented by biochemical and mutational analysis revealed several key residues critical for ISG15 recognition and interaction.
Structure of USP18
The USP18 crystals diffracted to a resolution of 2.8 A and the protease crystallized with two molecules in the asymmetric unit. USP18 adopts the typical threedomain USP fold with finger, palm, and thumb domains The catalytic triad of USP18 without ISG15 bound is not in catalytic configuration. The catalytic triad consists of residues Cys61, His314, and Asn331. In this conformation, the distance between the Cys61 thiol and His314 is too large and Cys61 is not activated. (C) Superposition of the two USP18 molecules (chains A, B) present in the asymmetric unit. Chain A is shown in red, chain B in blue. Major conformational differences are present in the finger domain and the switching loop. In chain A (red), the finger domain adopts a conformation compatible with ISG15 binding, whereas in chain B (blue), the ISG15 binding site is occluded. The switching loop either folds into an a-helix (chain A) incompatible with ISG15 binding or into a loop without secondary structure (chain B) which provides enough space for interaction with ISG15. (Fig. 1A) . The catalytic triad of USP18 is formed by residues Cys61, His314, and Asn331 (Fig. 1B) . These residues are not perfectly aligned for catalysis and need rearrangements to allow for ISG15 deconjugation.
Comparison of the two molecules in the asymmetric unit revealed that USP18 had crystallized in two conformations that mainly differ in the orientation of the finger domain (Fig. 1C) . With respect to ISG15 binding, these two orientations can be described as open (active) and closed (inactive) conformations. In contrast to the finger domain, the overall structure and orientation of thumb and palm domains are virtually identical. Only one loop in the thumb domain (previously described as switching loop [17] ) differs substantially between both molecules: In one molecule, it folds into a small a-helix, and in the other molecule, it forms a loop without secondary structure (Fig. 1C) . With respect to ISG15 binding, these conformations can be described as binding competent and incompetent: Although the loop conformation would provide enough space for ISG15 binding, the ahelix blocks binding of ISG15 molecule. Overall, the USP18 structure is similar to known structures of ubiquitin-deconjugating USPs [18] [19] [20] . Hence, the structure of USP18 alone does not provide an obvious explanation for the unique specificity toward ISG15.
USP18 recognizes the C-terminal Ubl domain of ISG15
While ubiquitin folds into one single domain, ISG15 consists of two ubiquitin-like domains that are connected by a small linker [2, 21] . For some cross-reactive DUBs, it has been shown that most likely both N-and C-terminal domain of ISG15 are recognized by the enzyme [22, 23] and it was appealing to speculate that recognition of both ubiquitin-like domains accounts for the ISG15 specificity of USP18 as such a binding would clearly differ from the binding of ubiquitin to USPs. In addition, it has been suggested that both ISG15 domains are required for proper ISGylation [24] . To uncover how USP18 recognizes ISG15 and how this interaction differs from binding of ubiquitin to other USPs, we determined the crystal structure of a mouse USP18-ISG15 complex at a resolution of 3.0 A. The complex crystallized with two USP18 and two ISG15 molecules in the asymmetric unit. USP18 makes extensive contacts to the C-terminal domain of ISG15: All three USP18 domains contribute to accommodating the C-terminal Ubl domain, and the C-terminal tail of ISG15 lies in a cleft between palm and thumb domain and reaches the catalytic triad. Unexpectedly, no interaction between USP18 and the N-terminal Ubl domain of ISG15 is present in the crystal structure and the orientation of the Ubl domains even differed in both complexes ( Fig. 2A) : Relative to the C-terminal domain, the N-terminal Ubl domain rotates about 10°around the linker region. Notably, in both complexes, the individual domains of ISG15 interact via Phe41 of the N-terminal domain and Gly136 of the C-terminal domain (Fig. 2B) . We concluded that only the C-terminal domain of ISG15 is recognized by USP18 and that the N-and C-terminal domain of ISG15 can rotate against each other if the contact between the glycine and the phenylalanine residue is maintained.
Structural basis of USP18 activity and specificity
As the N-terminal domain of ISG15 does not contribute to USP18 binding, the specificity of USP18 must be mediated by interactions between USP18 and the C-terminal Ubl domain. In both complexes, the conformation of USP18 is virtually identical. The switching loop exhibits no secondary structure and the residues of the catalytic triad adopt a catalytically competent orientation. Relative to the open and closed conformations of the finger domain in free USP18, the finger domain in the complex adopts an intermediate orientation. Most likely ISG15 binding reduces the conformational flexibility of USP18 so that the enzyme adopts a catalytically competent conformation. The orientation of the ISG15 C-terminal domain bound to USP18 is very similar to ubiquitin bound to other USPs [18, 20] . Likewise, the C-terminal residues of ISG15 (LRLRGG) that are conserved between ISG15 and ubiquitin, interact with USP18 in a similar way as ubiquitin does with ubiquitin-deconjugating USPs [18] [19] [20] 22] . Hence, additional interactions must ensure the remarkable specificity of USP18 toward ISG15. A characteristic hydrophobic patch protrudes on the surface of ISG15. This is centered around Trp121. For the viral cross-reactive DUB vOTU, it has already been shown that this hydrophobic patch must be properly oriented to allow deISGylation [25] . The USP18 residues Ala138, Leu142, and His251 form a hydrophobic pocket that, together with Gln139 and Ser192, accommodates the hydrophobic bulb of ISG15. We defined this pocket as IBB-1 (ISG15-binding box 1) (Fig. 2C) . In ubiquitin, such a hydrophobic patch is not present and replacement of ISG15 Trp121 with arginine-the respective residue of ubiquitinclearly decreases the affinity between ISG15 and USP18. Moreover, replacement of the hydrophobic pocket residues of USP18 with the respective residues of USP7-a ubiquitin-specific USP-entirely abolished the enzymatic activity of USP18. Hence, the high specificity of USP18 is accomplished by recognition of the characteristic hydrophobic patch in ISG15 and this property constitutes a prerequisite for its activity. Nevertheless, USP18 lacking the hydrophobic residues still bound ISG15 with reasonable affinity, suggesting that the hydrophobic interaction between USP18 and ISG15 is critical for the specificity of the enzyme but not for the interaction between the proteins.
Species-specific differences and putative evolutionary origin
In contrast to ubiquitin, ISG15 is much less conserved among different species and, e.g., human and mouse ISG15 share a sequence identity of only 66%. Some studies suggested that the mode of interaction between USP18 and ISG15 might fundamentally differ between Fig. 2 . Structure of the USP18-ISG15 complex (PDB 5CHV). (A) Superposition of both USP18-ISG15 complexes present in the asymmetric unit. As the USP18 conformation is virtually identical between both chains, only one USP18 molecule (blue) is shown. USP18 binds to the C-terminal Ubl domain of ISG15 (green and orange). No contact between the N-terminal domain of ISG15 and USP18 is present and the relative orientation of the two ISG15 domains differs in both complexes. (B) Close-up view of the interface between the N-and C-terminal domain of ISG15. The side chain of Phe41 (N-terminal Ubl domain) interacts via a p-p stacking with the peptide bond of Gly136 (C-terminal Ubl domain). (C) IBB-1 (magenta) of USP18 (blue) is formed by residues Ala138, Leu142, Gln139, Ser192, and His251, which are located in thumb and palm domain, and accommodates the hydrophobic patch of ISG15 (green). This patch is mainly formed by Trp121. The hydrophobic character is maintained by Pro128 and the orientation of Trp128 is stabilized by a p-p contact with His149. (D) Left, a putative further site in USP18 that mediates recognition of ISG15 is located between the finger and the palm domain (highlighted in dark red). This rim accommodates the bulky and polar Glu87 and Arg88 of ISG15 (left). Middle, a model of USP18 (light blue) from zebrafish indicates that this interaction might be conserved. Right, the corresponding residues of ubiquitin (light red)-Leu8 and Thr9-do not interact with ubiquitinspecific USP7 (gray).
the human and mouse proteins [26] . However, the hydrophobic surfaces on USP18 and ISG15 are well conserved between different mammals. Concordantly, we could show that IBB-1 in mouse and human USP18 is critical for its activity providing strong evidence that the overall mode of binding and deISGylation does not differ among mammals [16] . Interestingly, fish ISG15 does not contain the hydrophobic surface patch characteristic for mammalian ISG15 proteins, as Trp121 and Pro128 are replaced by arginine and glutamine residues, respectively. Notably, in ubiquitin, exactly these amino acids are present at the corresponding positions. The more hydrophilic nature of fish ISG15 is reflected by compensatory replacement of the mouse IBB-1 residues alanine and leucine by aspartate and histidine. Thus, fish USP18 to a certain extent shows higher similarity with ubiquitin-deconjugating DUBs, and our experimental data show that-in contrast to mammalian USP18-it also exhibits activity toward ubiquitin. Nevertheless, fish USP18 reacts readily with mouse ISG15, even with a higher efficiency. It is therefore likely that additional residues are involved that allow binding of mammalian ISG15 but not of ubiquitin. Candidates for such residues might be located between the finger and the thumb domain forming a rim that interacts with two charged residues (Glu87, Arg88) in mammalian ISG15 (Fig. 2D) . These charged residues are well conserved in ISG15 from different fish species. In contrast, the corresponding residues in ubiquitin, Leu8 and Thr9, carry no charge and do not interact with residues of USPs (Fig. 2D) . We speculate that during evolution, ISG15 and ubiquitin developed from a common precursor and were both deconjugated by cross-reactive proteases before specific deISGylation by USP18 evolved in higher organisms. Strict substrate specificity of USP18 is most likely very important. Upon stimulation with type I IFN, the cellular levels of USP18 levels are rather high. An ISG15-Ub crossreactive USP might interfere with ubiquitin-dependent signaling with deleterious effects. Introduction of complementary hydrophobic regions in ISG15 and USP18 in mammals ensured the specific interaction of the two proteins.
Conclusions and future directions
Selective inactivation of only the protease activity of USP18 in mice results in higher resistance to viral infections [8] . Therefore, blocking the enzymatic activity of USP18 might constitute an attractive novel antiviral strategy. Based on the structure, it might be possible to screen for and develop specific USP18 inhibitors that have the potential to increase viral resistance in vivo. These compounds might either target the active site of USP18 or block the IBB-1 region to abrogate enzyme activity. Moreover, a different class of allosteric inhibitors might trap USP18 in the catalytically inactive state. While the structures of USP18 and the USP18-ISG15 complex provide insights into the molecular mechanism of deISGylation, little is known about the structural basis of the role of USP18 as a negative regulator of IFN signaling, which is exerted in a protease-independent manner. Mice that lack USP18 and humans with mutations in USP18 develop severe interferonopathies [12, 27] . USP18 was reported to bind to the type I IFN receptor subunit IFNAR2 as well as to STAT2. The molecular basis of these interactions is currently unclear. IFNAR2 was suggested to bind to the C-terminal part of USP18 while for binding to STAT2 both N-and C-terminal domains of USP18 seem to be important [15] . However, the particular residues that mediate these interactions are not identified to date. Whether enzymatic and nonenzymatic functions of USP18 influence each other is also not understood. As USP18 basically consists of the catalytic core one could expect that ISG15 binding might interfere with STAT2 or IFNAR2 interaction. This raises the question whether USP18 bound to ISG15 is still able to bind to IFNAR2. And once bound to the receptor complex, is USP18 still able to deISGylate target proteins? Does binding to STAT2 and IFNAR2 induce conformational changes in the enzyme? Finally, it is well conceivable that additional adaptors and proteins influence both enzymatic and nonenzymatic functions of USP18, and identification of these factors might be critical to fully understand the function and regulation of USP18. Within this context, it is interesting to note that the N-terminal Ubl domain of ISG15 is not essential for USP18 binding and activity and would be a perfect hub to recruit additional proteins.
